Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1712665

registered interest
date	22/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Attention Deficit Hyperactivity Disorder: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions she has had with her counterparts in the devolved administrations on ensuring (a) a consistent approach and (b) the applicability of the NHS National Review to ADHD services.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	22949
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>My Rt hon. Friend, the Secretary of State for Health and Social Care has regular discussions on a wide range of matters, with a wide range of people. NHS England is establishing a new attention deficit hyperactivity disorder (ADHD) taskforce alongside the Government, to improve care for people living with the condition. The new taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, and help provide a joined-up approach in response to concerns around rising demand for assessments and support. NHS England will continue to engage widely throughout the process, and will engage with the devolved administrations as appropriate.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 25/04/2024 16:55:48 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1712667

registered interest
date	22/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to (a) trial and (b) roll-out early cancer screening.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	22951
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>In England, early cancer screening is already in place for cervical, breast, and bowel cancer. The UK National Screening Committee (UK NSC) does not currently recommend screening for prostate cancer due to the inaccuracy of the current best test, called Prostate Specific Antigen. We are providing £16 million of funding to Prostate Cancer UK's £42 million trial, which is aimed at helping us find a way of catching prostate cancer in men as early as possible. The UK NSC is also commissioning evidence for six possible approaches to targeted prostate screening for those at higher risk. The UK NSC will publish its recommendations when complete.</p><p>NHS England is responsible for the running of the Targeted Lung Health Check Programme, and its conversion to a nationally rolled out NHS Targeted Lung Cancer Screening Programme by 2030.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/04/2024 14:48:02 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1701263

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Semaglutide: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase the public's awareness of the side effects that can arise from taking weight loss drugs such as Ozempic.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	21989
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) plays a pivotal role in ensuring the safety, efficacy, and quality of medicines and healthcare products available to patients in the United Kingdom. Patient safety remains the MHRA’s highest priority, and they take every opportunity to encourage reporting of any safety concerns to the Yellow Card scheme, which helps to improve the safe use of medicines and medical devices for everyone.</p><p>New medicines including, Mounjaro and Wegovy, are intensively monitored to ensure that any new safety concerns are identified promptly. The Commission on Human Medicines and the MHRA encourages the reporting of all suspected reactions to newer drugs and vaccines, which are denoted by an inverted Black Triangle symbol. This symbol appears next to the name of a relevant product in drug safety updates, the British National Formulary and the Nurse Prescribers’ Formulary, the monthly index of medical specialities, the electronic medicines compendium, and advertising material. Patient information leaflets accompanying licensed medicines in the UK must include a description of the adverse reactions which may occur in normal use of the medicinal product, as well as information on how to report them. All adverse reactions must be reflected in the leaflet, in language that the patient will understand.</p><p>The MHRA has received a small number of reports of falsified and unlicenced medicines being sold illegally online as a treatment for weight loss. The agency has issued public health messaging warning of the dangers of buying such medicines from illegal trading sources online.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/04/2024 11:07:07 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1701266

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to improve early intervention for mental health conditions in working-age adults.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	21992
answer	answer is ministerial correction date of answer 22/04/2024 answer text <p>The £795 million of additional funding announced in the Autumn Statement will see thousands of working-age adults with mental ill health helped back into work over the next five years, keeping them out of poverty, improving their wellbeing, and raising their living standards.</p><p>This will increase the number of sessions per course of Talking Therapies treatment, to tackle the root causes of common mental health conditions like anxiety and depression and to broaden access, leading to an expected additional 384,000 people completing a course of treatment by 2028/29.</p><p>The investment will also fund an additional 100,000 Individual Placement and Support places over five years, which will help people with severe mental illness gain and retain paid employment.</p><p>Between 2019 and 2022, total number of NHS Talking Therapies staff across England, including clinical and non-clinical, has risen by 38%. NHS England has published a positive practice guide for NHS Talking Therapies staff working with those from black and ethnic minority groups, which is helping providers take appropriate action to ensure that communities have equality of access to NHS Talking Therapies</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 22/04/2024 16:07:46 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1701335

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2024 to Question 15636 on Blood Cancer: Drugs, on what date her Department first became aware of challenges presented by the appraisal of combination therapies; and what solutions her Department is considering with NHS England to ensure continued equal access to combination medicines for multiple myeloma across the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	21993
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>NHS England, the National Institute for Health and Care Excellence (NICE), and the Association of the British Pharmaceutical Industry (ABPI) worked closely with the Competition and Markets Authority (CMA) over a number of years on the CMA’s statement on combination therapies, published in November 2023.</p><p>The steps taken by the CMA provide a clear commercial position that means that deals involving multiple drugs licensed by different companies can now be agreed under specific circumstances. This has been welcomed by the ABPI as an opportunity to unlock the door to more transformative combination therapies on the National Health Service.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/04/2024 15:37:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1701336

registered interest
date	16/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will have discussions with NHS England on the effectiveness of its Commercial Framework in tackling challenges presented by the appraisal and reimbursement system when applied to combination medicines and medicines with multiple indications.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	21994
answer	answer is ministerial correction date of answer 24/04/2024 answer text <p>As part of the 2024 voluntary scheme for branded medicines pricing, access, and growth, NHS England has committed to undertake two consultations on its Commercial Framework for New Medicines. The first of these will be launched in summer 2024 and will align with the Competition and Markets Authority’s (CMA) statement on combination medicines. In addition, it will be more explicit about the approach taken for assessing the eligibility of medicines treating multiple indications to qualify for indication specific pricing mechanisms.</p><p>Following the first consultation, a revised framework will be published by the end of 2024, and engagement with pharmaceutical companies and patient groups on these issues is already taking place.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 24/04/2024 15:42:59 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1698374

registered interest
date	25/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the uptake of the cervical cancer vaccine.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	20311
answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The routine human papillomavirus (HPV) vaccination programme for adolescents offers a life-saving vaccine to all children in Year 8, to protect them against strains of HPV that can cause some cancers including cervical, anal, head, and neck. High-risk HPV DNA is found in over 99% of all cervical cancers. The UKHSA monitors uptake of the adolescent HPV vaccination programme, and publishes annual statistics for England and the United Kingdom, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023" target="_blank">https://www.gov.uk/government/statistics/human-papillomavirus-hpv-vaccine-coverage-estimates-in-england-2022-to-2023</a></p><p>This data is used by local NHS Screening and Immunisation Teams to develop local plans to improve uptake and reduce inequalities, in collaboration with key partners such as directors of public health, and their teams in local authorities. Publication of statistical data also generates national communication activity, to raise awareness and improve uptake.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 15/04/2024 08:52:54 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1697024

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to encourage the uptake of HPV vaccinations in schools.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	19354
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>National Health Service Commissioned School Aged Immunisation Service providers have robust catch-up plans in place for the adolescent human papillomavirus (HPV) vaccination programme based on population need, utilising opportunities from the move to one dose in September 2023.</p><p>The UK Health Security Agency (UKHSA) works closely with several charities to develop resources that can be used to raise awareness of HPV. UKHSA also publishes annual statistics to support local NHS teams in developing plans to improve HPV uptake and reduce inequalities.</p><p>NHS England has improved digital communications on vaccinations, including expanding the NHS app, and improved vaccine access outside of schools through community clinics at convenient times and locations. UKHSA produces a number HPV resources which are available at the following link:</p><p><a href="https://www.gov.uk/government/collections/hpv-vaccination-programme" target="_blank">https://www.gov.uk/government/collections/hpv-vaccination-programme</a></p><p>Other materials are available on the UKHSA Health Publications website in a range of language and accessible formats, which are available at the following link:</p><p><a href="https://www.healthpublications.gov.uk/Home.html" target="_blank">https://www.healthpublications.gov.uk/Home.html</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 26/03/2024 11:14:33 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1697025

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Measles: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many diagnoses of measles there have been in the last 12 months.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	19355
answer	answer is ministerial correction date of answer 26/03/2024 answer text <p>The UK Health Security Agency (UKHSA) publishes routine data on laboratory confirmed measles.</p><p>Between 1 January 2023 and 31 December 2023, there have been 368 laboratory confirmed cases in the England. From 1 October 2023, there have been 730 laboratory confirmed measles cases reported in England.</p><p>The 2023 data is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-epidemiology-2023/confirmed-cases-of-measles-in-england-by-month-age-and-region-2023" target="_blank">https://www.gov.uk/government/publications/measles-epidemiology-2023/confirmed-cases-of-measles-in-england-by-month-age-and-region-2023</a></p><p>As part of the national incident response, 2024 data is currently being published weekly at the following link:</p><p><a href="https://www.gov.uk/government/publications/measles-epidemiology-2023/national-measles-standard-incident-measles-epidemiology-from-october-2023" target="_blank">https://www.gov.uk/government/publications/measles-epidemiology-2023/national-measles-standard-incident-measles-epidemiology-from-october-2023</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 26/03/2024 11:18:34 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1697030

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Oral Cancer: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the number of people diagnosed with mouth cancer in the last twelve months.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	19359
answer	answer is ministerial correction date of answer 27/03/2024 answer text <p>The information requested is not available for the last twelve months. The most recent data available from 2021 shows 9,018 people were diagnosed with mouth cancer in England. Further information is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/cancer-registration-statistics/england-2021---summary-counts-only</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 27/03/2024 10:13:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon